Skip to main content

Table 2 Predicted versus observed mean utility values for models based on health states

From: Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

Model Health state EORTC-8D SF-6D
Predicted Observed Predicted Observed
Model 1 Pre-progression 0.803 0.813 0.642 0.648
  Post-progression 0.755 0.776 0.612 0.626
Model 2 180 or more days to death 0.831 0.840 0.667 0.672
  120 - 179 days to death 0.771 0.767 0.616 0.610
  90 - 119 days to death 0.763 0.756 0.613 0.600
  60 - 89 days to death 0.720 0.723 0.585 0.574
  30 - 59 days to death 0.679 0.670 0.557 0.541
  Under 30 days to death 0.653 0.651 0.544 0.531
Model 3 Pre-progression     
  180 or more days to death 0.837 0.848 0.670 0.677
  120 - 179 days to death 0.779 0.777 0.620 0.615
  90 - 119 days to death 0.772 0.759 0.613 0.591
  60 - 89 days to death 0.731 0.737 0.585 0.588
  30 - 59 days to death 0.695 0.690 0.557 0.554
  Under 30 days to death 0.672 0.629 0.544 0.518
  Post-progression     
  180 or more days to death 0.808 0.820 0.654 0.661
  120 - 179 days to death 0.749 0.742 0.614 0.595
  90 - 119 days to death 0.743 0.750 0.613 0.623
  60 - 89 days to death 0.702 0.693 0.585 0.547
  30 - 59 days to death 0.665 0.643 0.507 0.521
  Under 30 days to death 0.642 0.675 0.534 0.547